| 靶点: |
IC50: 0.5 μM (BMI-1, in HT1080 tumor cells) |
| 体内研究: |
PTC-209 (60 mg/kg body weight; subcutaneously; once a day for 11 days) significantly reduces tumor volume. |
| 参考文献: |
1. Kreso A, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nat Med. 2014 Jan;20(1):29-36. 2. Christian Mayr, et al. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells. Oncotarget. 2016 Jan 5; 7(1): 745-758. 3. Shahi MH, et al. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance. PLoS One. 2015 Jun 25;10(6):e0131006. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.736 ml |
8.679 ml |
17.358 ml |
| 5 mM |
0.347 ml |
1.736 ml |
3.472 ml |
| 10 mM |
0.174 ml |
0.868 ml |
1.736 ml |
| 50 mM |
0.035 ml |
0.174 ml |
0.347 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |